Biogen | BIIB - سرمایه گذاری در بازار





سرمایه گذاری در بازار تغییر دادن تاریخ
AbbVie USD 403.83B 5.2B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Bayer EUR 36.89B 535.42M 2026-03
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 265.66B 9.48B 2025-09
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12